Nonhuman primate (NHP) core cellular immunology laboratory for aids vaccine research development
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272201700022C
- Awardee
-
The Administrators Of Tulane Educational Fund UEI XNY5ULPU8EN6
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,764,234
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI201606 Solicitation number
- Nonhuman primate core cellular immunology laboratory for aids vaccine research and development Award Notice · Posted Apr 1, 2016
- Contract value 68% obligated
-
- $12,764,234.09 Current, with exercised options
- $18,887,126.09 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- New Orleans, LA 70112, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Funding Only Action | -$1,331 | |
| Other Administrative Action | $1,917,608 | |
| Exercise an Option | $0 | |
| Funding Only Action | -$6,147 | |
| Exercise an Option | $1,877,705 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,838,735 | |
| Exercise an Option | $1,800,685 | |
| Exercise an Option | $155,568 | |
| Exercise an Option | $1,763,507 | |
| Exercise an Option | $1,727,215 | |
| Original award | $1,690,690 |
Show all 13
About this award
The National Institute of Allergy and Infectious Diseases awarded a cost-no-fee definitive contract to The Administrators Of Tulane Educational Fund (doing business as Tulane University) for a nonhuman primate core cellular immunology laboratory supporting AIDS vaccine research and development, with a ceiling value of $18.9 million and an ultimate completion date of May 31, 2024. No set-aside was used.
The contract funds development and implementation of assays to evaluate and characterize cellular immune responses in nonhuman primates immunized with candidate HIV or SIV vaccines or infected with SIV, SHIV, or HIV-1. Place of performance is New Orleans, LA.
Under this contract, Tulane invoiced $1.8 million in FY2020, $1.7 million in FY2021, $1.9 million in FY2023, and $1.5 million in FY2024. Most recent labor footprint (FY2024) comprised 4.3 FTEs across 8,855 contractor hours. Government-paid hourly rates rose from $136.39/hr in FY2021 to $164.02/hr in FY2024. Tulane self-performed all reported hours with no subcontractors.
Quick answers
Who was awarded contract HHSN272201700022C?
HHSN272201700022C was awarded to The Administrators Of Tulane Educational Fund by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2017.
How much is contract HHSN272201700022C worth?
The government has obligated $12,764,234 on HHSN272201700022C. Its potential value, with all options, is $18,887,126.
Was contract HHSN272201700022C competed?
The extent of competition for HHSN272201700022C was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award